The estimated Net Worth of Wilfredo Ruiz Caban is at least 1.98 百万$ dollars as of 5 June 2020. Wilfredo Caban owns over 41,360 units of Conmed stock worth over 1,982,082$ and over the last 9 years Wilfredo sold CNMD stock worth over 0$.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wilfredo Caban CNMD stock SEC Form 4 insiders trading
Wilfredo has made over 6 trades of the Conmed stock since 2017, according to the Form 4 filled with the SEC. Most recently Wilfredo exercised 41,360 units of CNMD stock worth 1,686,247$ on 5 June 2020.
The largest trade Wilfredo's ever made was exercising 41,360 units of Conmed stock on 5 June 2020 worth over 1,686,247$. On average, Wilfredo trades about 2,242 units every 60 days since 2016. As of 5 June 2020 Wilfredo still owns at least 27,037 units of Conmed stock.
You can see the complete history of Wilfredo Caban stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Wilfredo Caban's mailing address?
Wilfredo's mailing address filed with the SEC is C/O CONMED CORPORATION, 525 FRENCH ROAD, UTICA, NY, 13502.
Insiders trading at Conmed
Over the last 5 years, insiders at Conmed have traded over 0$ worth of Conmed stock. The most active insiders traders include Curt R Hartman、Daniel S Jonas、Terence M Berge. On average, Conmed executives and independent directors trade stock every 0 days with the average trade being worth of 58,501$. The most recent stock trade was executed by John Jed Kennedy on 28 February 2020, trading 1,575 units of CNMD stock currently worth 115,463$.
What does Conmed do?
conmed corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. our products are technological leaders in the specialties that we serve: orthopaedics, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology. conmed's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. our emphasis is on our customer’s satisfaction and on our enhanced patient outcomes. we strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. conmed is headquartered in beautiful, upstate new york (utica), and employs approximately 3500
What does Conmed's logo look like?
Complete history of Wilfredo Caban stock trades at Conmed、Conmed
Conmed executives and stock owners
Conmed executives and other stock owners filed with the SEC include:
-
Curt R. Hartman,
Chairman, CEO & Pres -
Patrick J. Beyer,
Pres of International & Global Orthopedics -
Todd W. Garner,
Exec. VP & CFO -
Daniel S. Jonas Esq.,
Exec. VP of Legal Affairs, Gen. Counsel & Sec. -
Stanley W. Peters III,
VP & GM of U.S. Advanced Surgical -
John E. Kennedy,
Group Exec. VP of Advanced Endoscopic Technologies, QA/RA, Distribution & Customer Service -
David R. Murray,
Pres of ConMed Electrosurgery -
Shanna L. Cotti-Osmanski,
Exec. VP of Information Technology & CIO -
Heather L. Cohen,
Exec. VP of HR -
Peter K. Shagory,
Exec. VP of Strategy & Corp. Devel. -
Daniel S. Jonas,
Exec. VP of Legal Affairs, Gen. Counsel & Sec. -
Terence M Berge,
VP-Corporate Controller -
Pat Beyer,
President - International -
Heather L Cohen,
EVP CORP HR -
Nathan Folkert,
VP GM Orthopedics -
Todd W Garner,
Executive Vice President & CFO -
Daniel S Jonas,
EVP Legal Affairs,Gen. Counsel -
Johonna Marie Pelletier,
Treasurer and VP, Tax -
Wilfredo Ruiz Caban,
EVP QA, RA and Operations -
Curt R Hartman,
President & CEO -
Stanley W Iii Peters,
VP GM Advanced Surgery -
Peter K Shagory,
EVP, STRAT & CORP DEVT -
John Jed Kennedy,
VP GM CET